Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DES ALIZES : revenue, balance sheet and financial ratios

PHARMACIE DES ALIZES is a French company founded 22 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LOUVERNE (53950), this company of category PME shows in 2022 a revenue of 3.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DES ALIZES (SIREN 450684485)
Indicator 2025 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 3 339 916 € N/C N/C N/C N/C N/C N/C
Net income 243 558 € 299 114 € 177 219 € 236 379 € 151 898 € 209 289 € 222 611 € 201 061 €
EBITDA N/C 431 393 € N/C N/C N/C N/C N/C N/C
Net margin N/C 9.0% N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE DES ALIZES generates positive net income of 244 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 201 k€ -> 244 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

243 558 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 67%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 53%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

66.913%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

52.851%

Solvency indicators evolution
PHARMACIE DES ALIZES

Sector positioning

Debt ratio
66.91 2025
2021
2022
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average -20 pts over 3 years

In 2025, the debt ratio of PHARMACIE DES ALIZES (66.91) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
52.85% 2025
2021
2022
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average +20 pts over 3 years

In 2025, the financial autonomy of PHARMACIE DES ALIZES (52.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
4.09 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of PHARMACIE DES ALIZES (4.09) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DES ALIZES

Positioning of PHARMACIE DES ALIZES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DES ALIZES is estimated at 3 868 947 € (range 2 625 486€ - 6 070 911€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2625k€ 3868k€ 6070k€
3 868 947 € Range: 2 625 486€ - 6 070 911€
NAF 5 année 2025

Valuation method used

Net Income Multiple
243 558 € × 15.9x = 3 868 948 €
Range: 2 625 486€ - 6 070 912€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DES ALIZES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DES ALIZES

What is the revenue of PHARMACIE DES ALIZES ?

The revenue of PHARMACIE DES ALIZES in 2022 is 3.3 M€.

Is PHARMACIE DES ALIZES profitable?

Yes, PHARMACIE DES ALIZES generated a net profit of 244 k€ in 2025.

Where is the headquarters of PHARMACIE DES ALIZES ?

The headquarters of PHARMACIE DES ALIZES is located in LOUVERNE (53950), in the department Mayenne.

Where to find the tax return of PHARMACIE DES ALIZES ?

The tax return of PHARMACIE DES ALIZES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DES ALIZES operate?

PHARMACIE DES ALIZES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.